Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care 2023-11-13 22:00
OliPass Discloses Painful but Hilarious Clinical Findings from a Phase 2a Trial in OA Patients with Nav1.7 Selective Inhibitor OLP-1002 2023-11-13 22:00
Datasea Reports First Quarter Fiscal Year 2024 Financial Results and Operations Update 2023-11-13 21:30
PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE 2023-11-13 21:00
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests 2023-11-13 21:00
So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange 2023-11-13 19:30
BizLink once again proves its ability to innovate in healthcare robotics 2023-11-13 17:53
Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates 2023-11-13 16:04
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow 2023-11-13 13:10
One-Stop Dental 3D Printing Solutions Provider to Showcase at the GNYDM 2023-11-13 10:53
PillWork Strengthens Global Ties Ahead of 2023 Launch with Strategic Partnerships 2023-11-13 08:00
Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA 2023-11-11 20:36
SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York 2023-11-10 21:00
Lecheng, MSD vow to deepen medical cooperation 2023-11-10 18:03
So-Young to Report Third Quarter 2023 Financial Results on November 20, 2023 2023-11-10 18:00
FEBICO actively seeking business partners in United States, introduces "High- Spermidine" chlorella health supplements to satisfy U.S. market 2023-11-10 17:08
TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert 2023-11-10 16:46
GC Genome Enters License Agreement with MP Group 2023-11-10 13:00
MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results 2023-11-10 08:00
Beyond2020 Improves Access to Clean Water for 10,000 Rural Malaysians 2023-11-10 03:27
1 63 64 65 66 67 812